SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filing Details

Document Details

Form
Filing Date
Aug 12, 2019
Document Date
Aug 8, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Jazz Pharmaceuticals plc
Issuer
JAZZ PHARMACEUTICALS PLC
Filer
McSharry Heather Ann